Posted on 27 March 2014. Tags: Birth Defects, child safety, dangerous drugs, medical malpractice, product safety
Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, was ordered by a Philadelphia jury to pay $3 million for a child’s birth injuries. The jury found that the injuries occurred as a result of the mother Kelly Anderson taking Janssen drug Topomax while pregnant. It was ruled that Janssen failed to provide adequate label information, […]
Read the full story
Posted in Consumer Protection, Legal News, Product Safety
Posted on 27 March 2014. Tags: civil justice magazine, dangerous drugs, medical malpractice, product safety
Dr. Carlos Zevallos has been found liable by an Ohio jury in a medical malpractice suit. He has now been ordered to pay $2.7 million for prescribing a toxic mixture of drugs, which lead to a terminal disease. In 2006, Debbie Neifer consulted with Dr. Zevallos, looking for treatment for her rheumatoid arthritis. He increased […]
Read the full story
Posted in Consumer Protection, Product Safety
Posted on 27 March 2014. Tags: child safety, civil justice magazine, dangerous drugs, product safety
Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, has agreed to a settlement of $5.9 million stemming from a 2008 Risperdal lawsuit. The suit accused the company of using illegal, unfair and deceptive practices when marketing the antipsychotic drug, according to The National Trial Lawyers. The lawsuit was originally filed by the Montana State Attorney […]
Read the full story
Posted in Civil Justice Update, Consumer Protection, Legal News, Product Safety
Posted on 02 February 2013. Tags: dangerous drugs
Merck & Co shareholders can forward with a class-action suit alleging the company misrepresented the safety of its arthritis drug Vioxx and that share prices fell when the true risk was disclosed. U.S. District Judge Stanley Chesler in Newark granted certification on Wednesday for a class of plaintiffs claiming the company’s statements violated the […]
Read the full story
Posted in Civil Justice Update
Posted on 28 September 2012. Tags: dangerous drugs
Recently the trend has been against cases like this. It is getting harder and harder for class actions to be certified. This case presents an interesting exposé on Merck marketing practices. CLASS ACTIONS VS. MERCK, SCHERING OVER VYTORIN GET JUDGE'S GO AHEAD A federal judge on Tuesday certified as class actions a pair of […]
Read the full story
Posted in Consumer Protection
Posted on 24 August 2012. Tags: dangerous drugs
In continuing coverage, ABC News (8/24, Neporent) reports on its website that the FDA has issued another Safety Warning about “Reumofan and Reumofan Plus,” which are marketed as “natural dietary supplements for treating arthritis, muscle pain, osteoporosis, bone cancer, and other conditions.” The agency said the supplements contain “several potentially dangerous ingredients that are […]
Read the full story
Posted in Community, Consumer Protection